Felix Rudolph
*
Maria Ivannikova
Tanja K. Rudolph
Muhammed Gerçek
Kai Friedrichs
The final, formatted version of the article will be published soon.
REVIEW article
Front. Cardiovasc. Med.
Sec. General Cardiovascular Medicine
Volume 11 - 2024 |
doi: 10.3389/fcvm.2024.1447411
This article is part of the Research Topic Tricuspid regurgitation - Time to assess more than the prognosis View all articles
Time to assess more than prognosis: Advancements and challenges in transcatheter tricuspid valve interventions
Provisionally accepted- Heart and Diabetes Center North Rhine-Westphalia, Bad Oeynhausen, Germany
We provide an overview about the current landscape of transcatheter tricuspid valve interventions (TTVI) and summarize recent findings from trials including TRILUMINATE, TRILUMINATE Pivotal, bRIGHT, TRICLASP, TRISCEND, TRISCEND II, TRICUS, and Cardioband TR EFS. These studies have demonstrated the safety and efficacy of TTVI. Yet, they have failed to show a prognostic benefit over conservative treatment. On the other hand, significant improvements in health status assessments have been observed. Assessment of right ventricular (RV) function prior to tricuspid interventions is crucial, as changes in preload and afterload may lead to RV failure which is associated with a high mortality. Therefore, this review emphasizes the impact of TTVIs on quality of life and explores the influence of RV dysfunction on therapeutic success and prognosis.
Keywords: TTVI, Quality of Life, Health Status, RV function, RV remodeling
Received: 11 Jun 2024; Accepted: 30 Jul 2024.
Copyright: © 2024 Rudolph, Ivannikova, Rudolph, Rudolph, Gerçek and Friedrichs. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Felix Rudolph, Heart and Diabetes Center North Rhine-Westphalia, Bad Oeynhausen, Germany
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.